{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:13:22Z","timestamp":1793412802732,"version":"4.5.0"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/wco.0b013e3283480569","type":"journal-article","created":{"date-parts":[[2011,5,14]],"date-time":"2011-05-14T07:07:03Z","timestamp":1305356823000},"page":"331-338","source":"Crossref","is-referenced-by-count":27,"title":["New insights into atypical parkinsonism"],"prefix":"10.1097","volume":"24","author":[{"given":"Gregor K.","family":"Wenning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krismer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Poewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20210206","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S1474-4422(09)70288-1","article-title":"Multiple system atrophy: an update.","volume":"8","author":"Stefanova","year":"2009","journal-title":"Lancet Neurol"},{"key":"R3-5-20210206","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.21465","article-title":"Multiple system atrophy: a primary oligodendrogliopathy.","volume":"64","author":"Wenning","year":"2008","journal-title":"Ann Neurol"},{"key":"R4-5-20210206","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1523\/JNEUROSCI.0567-10.2010","article-title":"Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.","volume":"30","author":"Ubhi","year":"2010","journal-title":"J Neurosci"},{"key":"R5-5-20210206","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2353\/ajpath.2007.070201","article-title":"p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy.","volume":"171","author":"Song","year":"2007","journal-title":"Am J Pathol"},{"key":"R6-5-20210206","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuint.2010.09.002","article-title":"Role of TPPPp25 on alpha-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy.","volume":"57","author":"Hasegawa","year":"2010","journal-title":"Neurochem Int"},{"key":"R7-5-20210206","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tins.2010.04.003","article-title":"The propagation of prion-like protein inclusions in neurodegenerative diseases.","volume":"33","author":"Goedert","year":"2010","journal-title":"Trends Neurosci"},{"key":"R8-5-20210206","first-page":"368","article-title":"Striatal transplantation for multiple system atrophy-are grafts affected by alpha-synucleinopathy Exp N","volume":"219","author":"Stefanova","year":"2009","journal-title":"eurol"},{"key":"R9-5-20210206","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2011.01.005","article-title":"Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro alpha-synuclein fibril formation.","volume":"491","author":"Hirohata","year":"2011","journal-title":"Neurosci Lett"},{"key":"R10-5-20210206","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.21685","article-title":"SNCA variants are associated with increased risk for multiple system atrophy.","volume":"65","author":"Scholz","year":"2009","journal-title":"Ann Neurol"},{"key":"R11-5-20210206","doi-asserted-by":"crossref","first-page":"e7114","DOI":"10.1371\/journal.pone.0007114","article-title":"Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy.","volume":"4","author":"Al-Chalabi","year":"2009","journal-title":"PLoS One"},{"key":"R12-5-20210206","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ana.21786","article-title":"Reply to: SNCA variants are associated with increased risk of multiple system atrophy.","volume":"67","author":"Ross","year":"2010","journal-title":"Ann Neurol"},{"key":"R13-5-20210206","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.21889","article-title":"SNCA variants and multiple system atrophy.","volume":"67","author":"Yun","year":"2010","journal-title":"Ann Neurol"},{"key":"R14-5-20210206","first-page":"545","article-title":"Multiplex families with multiple system atrophy.","volume":"64","author":"Hara","year":"2007","journal-title":"ArchNeurol"},{"key":"R15-5-20210206","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/jnnp.2008.158949","article-title":"Definite multiple system atrophy in a German family.","volume":"80","author":"Wullner","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R16-5-20210206","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/mds.23192","article-title":"Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.","volume":"25","author":"Kollensperger","year":"2010","journal-title":"Mov Disord"},{"key":"R17-5-20210206","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00415-009-5255-7","article-title":"Nonmotor symptoms in atypical and secondary parkinsonism: the PRIAMO study.","volume":"257","author":"Colosimo","year":"2010","journal-title":"J Neurol"},{"key":"R18-5-20210206","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy.","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"issue":"Pt 8","key":"R19-5-20210206","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awq158","article-title":"Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.","volume":"133","author":"Brown","year":"2010","journal-title":"Brain"},{"key":"R20-5-20210206","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneurol.2010.359","article-title":"Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).","volume":"68","author":"Moreno-Lopez","year":"2011","journal-title":"Arch Neurol"},{"key":"R21-5-20210206","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1212\/WNL.0b013e3181ec7fac","article-title":"REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.","volume":"75","author":"Claassen","year":"2010","journal-title":"Neurology"},{"issue":"Pt 3","key":"R22-5-20210206","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/brain\/awq379","article-title":"The improvement of movement and speech during rapid eye movement sleep behaviour disorder in multiple system atrophy.","volume":"134","author":"Cochen De Cock","year":"2011","journal-title":"Brain"},{"key":"R23-5-20210206","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.22794","article-title":"A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy.","volume":"25","author":"Schrag","year":"2010","journal-title":"Mov Disord"},{"key":"R24-5-20210206","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s00415-010-5661-x","article-title":"Putaminal abnormality on 3-T magnetic resonance imaging in early parkinsonism-predominant multiple system atrophy.","volume":"257","author":"Lee","year":"2010","journal-title":"J Neurol"},{"key":"R25-5-20210206","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/mds.23318","article-title":"Callosal tissue loss in multiple system atrophy-a one-year follow-up study.","volume":"25","author":"Minnerop","year":"2010","journal-title":"Mov Disord"},{"key":"R26-5-20210206","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.10090988","article-title":"Microstructural white matter abnormalities of multiple system atrophy: in vivo topographic illustration by using diffusion-tensor MR imaging.","volume":"255","author":"Tha","year":"2010","journal-title":"Radiology"},{"key":"R27-5-20210206","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1474-4422(10)70002-8","article-title":"Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis.","volume":"9","author":"Tang","year":"2010","journal-title":"Lancet Neurol"},{"key":"R28-5-20210206","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s00259-010-1681-0","article-title":"A novel computer-assisted image analysis of (123)Ibeta-CIT SPECT images improves the diagnostic accuracy of parkinsonian disorders.","volume":"38","author":"Goebel","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R29-5-20210206","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S1474-4422(10)70216-7","article-title":"Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study corrected.","volume":"9","author":"Iranzo","year":"2010","journal-title":"Lancet Neurol"},{"key":"R30-5-20210206","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1212\/WNL.0b013e3181f4d78f","article-title":"Motor activation in multiple system atrophy and Parkinson disease: a PET study.","volume":"75","author":"Payoux","year":"2010","journal-title":"Neurology"},{"key":"R31-5-20210206","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","article-title":"Cardiac uptake of 123IMIBG separates Parkinsons disease from multiple system atrophy.","volume":"53","author":"Braune","year":"1999","journal-title":"Neurology"},{"key":"R32-5-20210206","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/mds.23338","article-title":"Abnormal cardiac (123)I-meta-iodobenzylguanidine uptake in multiple system atrophy.","volume":"25","author":"Nagayama","year":"2010","journal-title":"Mov Disord"},{"key":"R33-5-20210206","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00401-006-0160-y","article-title":"Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy.","volume":"113","author":"Orimo","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"Pt 6","key":"R34-5-20210206","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/brain\/awq091","article-title":"In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-2-(2-dimethylaminothiazol-5-yl)ethenyl-6-2-(fluoro)ethoxybenzoxazole positron emission tomography in multiple system atrophy.","volume":"133","author":"Kikuchi","year":"2010","journal-title":"Brain"},{"key":"R35-5-20210206","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archneurol.2009.71","article-title":"Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.","volume":"66","author":"Lipp","year":"2009","journal-title":"Arch Neurol"},{"key":"R36-5-20210206","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s00415-010-5645-x","article-title":"Urodynamic analysis in multiple system atrophy: characterisation of detrusor-sphincter dyssynergia.","volume":"257","author":"Bloch","year":"2010","journal-title":"J Neurol"},{"issue":"Suppl 1","key":"R37-5-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10286-007-1005-z","article-title":"L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.","volume":"18","author":"Mathias","year":"2008","journal-title":"Clin Auton Res"},{"issue":"Suppl 1","key":"R38-5-20210206","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10286-007-1002-2","article-title":"L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.","volume":"18","author":"Kaufmann","year":"2008","journal-title":"Clin Auton Res"},{"key":"R39-5-20210206","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/mds.22732","article-title":"Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and (11)C (R)-PK11195 PET (MEMSA-trial).","volume":"25","author":"Dodel","year":"2010","journal-title":"Mov Disord"},{"key":"R41-5-20210206","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.clpt.6100386","article-title":"Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy.","volume":"83","author":"Lee","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"R42-5-20210206","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mds.23474","article-title":"Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy.","volume":"26","author":"Kollensperger","year":"2011","journal-title":"Mov Disord"},{"key":"R44-5-20210206","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"R45-5-20210206","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroscience.2005.06.047","article-title":"Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain.","volume":"135","author":"Totterdell","year":"2005","journal-title":"Neuroscience"},{"key":"R46-5-20210206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinsons disease and Parkinsons disease dementia.","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol"},{"key":"R47-5-20210206","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","article-title":"Initiation and synergistic fibrillization of tau and alpha-synuclein.","volume":"300","author":"Giasson","year":"2003","journal-title":"Science"},{"key":"R48-5-20210206","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic interactions between a beta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.","volume":"30","author":"Clinton","year":"2010","journal-title":"J Neurosci"},{"key":"R49-5-20210206","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JAD-2010-1356","article-title":"Comprehensive genetic and mutation analysis of familial dementia with Lewy bodies linked to 2q35-q36.","volume":"20","author":"Meeus","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"R50-5-20210206","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archneurol.2010.319","article-title":"Familial aggregation of dementia with Lewy bodies.","volume":"68","author":"Nervi","year":"2011","journal-title":"Arch Neurol"},{"key":"R51-5-20210206","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2010.09.036","article-title":"Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.","volume":"486","author":"Fujishiro","year":"2010","journal-title":"Neurosci Lett"},{"issue":"Pt 2","key":"R52-5-20210206","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/brain\/awp280","article-title":"Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study.","volume":"133","author":"Molano","year":"2010","journal-title":"Brain"},{"key":"R53-5-20210206","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1212\/WNL.0b013e3181e0f7cf","article-title":"Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI.","volume":"74","author":"Kantarci","year":"2010","journal-title":"Neurology"},{"key":"R54-5-20210206","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1212\/WNL.0b013e3181d55f61","article-title":"Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.","volume":"74","author":"Klein","year":"2010","journal-title":"Neurology"},{"key":"R56-5-20210206","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","article-title":"Memantine in patients with Parkinsons disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.","volume":"8","author":"Aarsland","year":"2009","journal-title":"Lancet Neurol"},{"key":"R57-5-20210206","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(10)70194-0","article-title":"Memantine for patients with Parkinsons disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.","volume":"9","author":"Emre","year":"2010","journal-title":"Lancet Neurol"},{"key":"R58-5-20210206","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges.","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol"},{"issue":"Pt 6","key":"R59-5-20210206","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardsons syndrome and PSP-parkinsonism.","volume":"128","author":"Williams","year":"2005","journal-title":"Brain"},{"key":"R60-5-20210206","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/mds.21698","article-title":"Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy.","volume":"22","author":"Williams","year":"2007","journal-title":"Mov Disord"},{"issue":"Pt 7","key":"R61-5-20210206","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awq123","article-title":"Does corticobasal degeneration exist A clinicopathological re-evaluation.","volume":"133","author":"Ling","year":"2010","journal-title":"Brain"},{"key":"R62-5-20210206","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1212\/WNL.0b013e3181feb2e8","article-title":"Imaging correlates of pathology in corticobasal syndrome.","volume":"75","author":"Whitwell","year":"2010","journal-title":"Neurology"},{"key":"R63-5-20210206","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/01.wnl.0000191307.69661.c3","article-title":"Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.","volume":"66","author":"Josephs","year":"2006","journal-title":"Neurology"},{"issue":"Pt 6","key":"R64-5-20210206","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/brain\/awq115","article-title":"Rational therapeutic approaches to progressive supranuclear palsy.","volume":"133","author":"Stamelou","year":"2010","journal-title":"Brain"},{"key":"R65-5-20210206","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1007\/s00415-010-5638-9","article-title":"Familial aggregation in atypical Parkinsons disease: a case control study in multiple system atrophy and progressive supranuclear palsy.","volume":"257","author":"Vidal","year":"2010","journal-title":"J Neurol"},{"key":"R66-5-20210206","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/hmg\/ddh138","article-title":"The structure of the tau haplotype in controls and in progressive supranuclear palsy.","volume":"13","author":"Pittman","year":"2004","journal-title":"Hum Mol Genet"},{"key":"R67-5-20210206","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/513320","article-title":"Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500288 single-nucleotide polymorphisms.","volume":"80","author":"Melquist","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"Pt 7","key":"R68-5-20210206","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/brain\/122.7.1233","article-title":"Clinical genetics of familial progressive supranuclear palsy.","volume":"122","author":"Rojo","year":"1999","journal-title":"Brain"},{"key":"R69-5-20210206","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000319454","article-title":"Novel L284R MAPT mutation in a family with an autosomal dominant progressive supranuclear palsy syndrome.","volume":"8","author":"Rohrer","year":"2011","journal-title":"Neurodegener Dis"},{"key":"R70-5-20210206","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jnnp.2009.195719","article-title":"Survival in progressive supranuclear palsy and frontotemporal dementia.","volume":"81","author":"Chiu","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R71-5-20210206","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mds.22902","article-title":"Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy.","volume":"25","author":"OSullivan","year":"2010","journal-title":"Mov Disord"},{"key":"R72-5-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"R73-5-20210206","first-page":"357","article-title":"What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P) Mov D","volume":"25","author":"Williams","year":"2010","journal-title":"isord"},{"key":"R74-5-20210206","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00415-010-5865-0","article-title":"Magnetic resonance imaging in progressive supranuclear palsy.","volume":"258","author":"Stamelou","year":"2011","journal-title":"J Neurol"},{"key":"R76-5-20210206","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/mds.23293","article-title":"MRI measurements of brainstem structures in patients with Richardsons syndrome, progressive supranuclear palsy-parkinsonism, and Parkinsons disease.","volume":"26","author":"Longoni","year":"2011","journal-title":"Mov Disord"},{"key":"R77-5-20210206","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/mds.23351","article-title":"Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinsons disease and the Parkinson variant of multiple system atrophy.","volume":"25","author":"Hussl","year":"2010","journal-title":"Mov Disord"},{"key":"R78-5-20210206","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1460-9568.2010.07304.x","article-title":"The in vivo distribution of brain tissue loss in Richardsons syndrome and PSP-parkinsonism: a VBM-DARTEL study.","volume":"32","author":"Agosta","year":"2010","journal-title":"Eur J Neurosci"},{"key":"R79-5-20210206","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/mds.23295","article-title":"Cortical atrophy differentiates Richardsons syndrome from the parkinsonian form of progressive supranuclear palsy.","volume":"26","author":"Schofield","year":"2011","journal-title":"Mov Disord"},{"key":"R80-5-20210206","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/mds.23054","article-title":"In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS.","volume":"25","author":"Knake","year":"2010","journal-title":"Mov Disord"},{"key":"R81-5-20210206","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1212\/WNL.0b013e3181dc1a55","article-title":"Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes.","volume":"74","author":"Gilman","year":"2010","journal-title":"Neurology"},{"key":"R83-5-20210206","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neurobiolaging.2007.05.009","article-title":"Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.","volume":"30","author":"Borroni","year":"2009","journal-title":"Neurobiol Aging"},{"key":"R84-5-20210206","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/156720507783018208","article-title":"NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell.","volume":"4","author":"Gozes","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"R85-5-20210206","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/mds.22023","article-title":"Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial.","volume":"23","author":"Stamelou","year":"2008","journal-title":"Mov Disord"},{"key":"R86-5-20210206","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1468-1331.2008.02513.x","article-title":"Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options.","volume":"16","author":"Ludolph","year":"2009","journal-title":"Eur J Neurol"},{"key":"R87-5-20210206","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/mds.22804","article-title":"H1H1 genotype influences symptom severity in corticobasal syndrome.","volume":"25","author":"Litvan","year":"2010","journal-title":"Mov Disord"},{"key":"R88-5-20210206","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2174\/156720510793611619","article-title":"Disentangling the role of the tau gene locus in sporadic tauopathies.","volume":"7","author":"Vandrovcova","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"R89-5-20210206","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","article-title":"Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.","volume":"61","author":"Dickson","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"R90-5-20210206","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-010-0702-1","article-title":"Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy.","volume":"120","author":"Yokota","year":"2010","journal-title":"Acta Neuropathol"},{"key":"R91-5-20210206","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","article-title":"Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.","volume":"67","author":"Uryu","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"R92-5-20210206","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mds.23341","article-title":"Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome.","volume":"26","author":"Aerts","year":"2011","journal-title":"Mov Disord"},{"issue":"Pt 7","key":"R94-5-20210206","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/awq120","article-title":"Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.","volume":"133","author":"Hirano","year":"2010","journal-title":"Brain"},{"key":"R95-5-20210206","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1073\/pnas.0500466102","article-title":"Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.","volume":"102","author":"Noble","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R96-5-20210206","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.107.130526","article-title":"A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimers disease.","volume":"325","author":"Matsuoka","year":"2008","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WCO.0b013e3283480569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:34:42Z","timestamp":1786044882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00019052-201108000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e3283480569","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}